File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1442-2042.2012.03167.x
- WOS: WOS:000308130600002
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Conference Paper: Asian clinical trials for new drug approval
Title | Asian clinical trials for new drug approval |
---|---|
Authors | |
Keywords | Medical sciences Urology and nephrology |
Issue Date | 2012 |
Publisher | Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/IJU |
Citation | The 2012 Asia-Pacific Society of Uro-oncology Symposium held in conjunction with the 11th Asian Congress of Urology (ACU), Pattaya, Thailand, 22-26 August 2012. In International Journal of Urology, 2012, v. 19 suppl. 1, p. 422, abstract APSU25-04 How to Cite? |
Abstract | One third of all industry sponsored phase III drug trial registered in the US trial registry are carried out in Asian. It significantly exceeded the proportion of non-industry sponsored drug trial in this area. With the driving force of the globalization, economic shift from the west to the east, relative the lack of investigators, patients etc. in established regions, Asia have nourished to become one of the most important global regions for drug trials. It is noted that the North East Asia represents more than two third of all industry-sponsored trial sites in Asia, in which most of them are phase II/III. It is predicted to become the most popular emerging clinical trial region in the coming years. In this presentation, some basic concepts of drug clinical trials will be elaborated. The current status of Asian drug clinical trials will also be discussed and analyzed. Hopefully this could provide some update on the recent situation and a more in-depth understanding to our own position in this aspect. |
Description | Abstract and Invited Lecture This journal suppl. entitled: Abstracts of the 11th Asian Congress of Urology of the Urological Association of Asia ... 2012 |
Persistent Identifier | http://hdl.handle.net/10722/169386 |
ISSN | 2023 Impact Factor: 1.8 2023 SCImago Journal Rankings: 0.663 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yiu, MK | en_US |
dc.date.accessioned | 2012-10-18T08:53:08Z | - |
dc.date.available | 2012-10-18T08:53:08Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.citation | The 2012 Asia-Pacific Society of Uro-oncology Symposium held in conjunction with the 11th Asian Congress of Urology (ACU), Pattaya, Thailand, 22-26 August 2012. In International Journal of Urology, 2012, v. 19 suppl. 1, p. 422, abstract APSU25-04 | en_US |
dc.identifier.issn | 0919-8172 | - |
dc.identifier.uri | http://hdl.handle.net/10722/169386 | - |
dc.description | Abstract and Invited Lecture | - |
dc.description | This journal suppl. entitled: Abstracts of the 11th Asian Congress of Urology of the Urological Association of Asia ... 2012 | - |
dc.description.abstract | One third of all industry sponsored phase III drug trial registered in the US trial registry are carried out in Asian. It significantly exceeded the proportion of non-industry sponsored drug trial in this area. With the driving force of the globalization, economic shift from the west to the east, relative the lack of investigators, patients etc. in established regions, Asia have nourished to become one of the most important global regions for drug trials. It is noted that the North East Asia represents more than two third of all industry-sponsored trial sites in Asia, in which most of them are phase II/III. It is predicted to become the most popular emerging clinical trial region in the coming years. In this presentation, some basic concepts of drug clinical trials will be elaborated. The current status of Asian drug clinical trials will also be discussed and analyzed. Hopefully this could provide some update on the recent situation and a more in-depth understanding to our own position in this aspect. | - |
dc.language | eng | en_US |
dc.publisher | Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/IJU | - |
dc.relation.ispartof | International Journal of Urology | en_US |
dc.rights | The definitive version is available at www.blackwell-synergy.com | - |
dc.subject | Medical sciences | - |
dc.subject | Urology and nephrology | - |
dc.title | Asian clinical trials for new drug approval | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Yiu, MK: pmkyiu@hku.hk | en_US |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1111/j.1442-2042.2012.03167.x | - |
dc.identifier.hkuros | 212264 | en_US |
dc.identifier.volume | 19 | en_US |
dc.identifier.issue | suppl. 1 | en_US |
dc.identifier.spage | 422 | en_US |
dc.identifier.epage | 422 | en_US |
dc.identifier.isi | WOS:000308130600002 | - |
dc.publisher.place | Australia | - |
dc.identifier.issnl | 0919-8172 | - |